Pulmatrix Inc. Company Profile
NASDAQ: PULMHealthcareBiotechnologyUSD
At close: Oct 8, 4:00 PM ET · Delayed 15 min
Pulmatrix at a glance
Pulmatrix Inc. (NASDAQ: PULM) is a Biotechnology company in the Healthcare sector headquartered in Framingham, MA. Pulmatrix is led by Mr. Peter Ludlum CMA, MBA and employs about 2 people. The company's shares have traded publicly since 2014.
At a market capitalization of $5.6 million, it is considered a small-cap company. Its SEC Central Index Key (CIK) is 0001574235, which identifies the company's filings on EDGAR.
Summary generated from market data by MetaCap's automated system. Methodology
What does Pulmatrix do?
Pulmatrix, Inc., a biopharmaceutical company, focused on development of novel inhaled therapeutic products to prevent and treat migraine and respiratory diseases with unmet medical needs in the United States. The company offers iSPERSE, an engineered dry powder delivery platform, which enables delivery of small or large molecule drugs to the lungs by inhalation for local or systemic applications. It engages in developing PUR1800, a narrow spectrum kinase inhibitor completed Phase 1b clinical trials for the treatment of acute exacerbations in chronic obstructive pulmonary disease; PUR1900 for the treatment of allergic bronchopulmonary aspergillosis in patients with asthma and cystic fibrosis; and PUR3100, an iSPERSE formulation of dihydroergotamine which is in Phase 1 for the treatment of acute migraine. It has a license agreement with RespiVert Ltd. for access to a portfolio of kinase inhibitor compounds. The company was founded in 2003 and is headquartered in Framingham, Massachusetts.
Business description based on the company's public filings.
Company information
- Legal name
- Pulmatrix Inc.
- Ticker
- NASDAQ: PULM
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Mr. Peter Ludlum CMA, MBA
- Employees
- 2
- Headquarters
- 945 Concord Street, Framingham, MA, United States
- Phone
- 888 355 4440
- Website
- pulmatrix.com
- IPO year
- 2014
- Market cap
- $5.58M
- SEC CIK
- 0001574235
Companies similar to Pulmatrix
| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| ADXNAddex Therapeutics Ltd ADR | 3.18 | +6.81% | $5.57M | vs PULM |
| ENLVEnlivex Ltd. | 0.277 | -10.85% | $5.51M | vs PULM |
| CDIOCardio Diagnostics Holdings Inc. | 1.86 | -5.58% | $5.50M | vs PULM |
| KALAKALA BIO Inc. | 0.2966 | -17.61% | $5.74M | vs PULM |
| DRMADermata Therapeutics Inc. | 1.07 | -4.46% | $5.30M | vs PULM |
| IMNNImunon Inc. | 1.07 | -4.46% | $6.00M | vs PULM |
| CANFCan-Fite Biopharma Ltd ADR | 2.00 | -4.76% | $6.06M | vs PULM |
| LNAILunai Bioworks Inc. | 1.12 | +2.75% | $5.08M | vs PULM |